Cone-rod synaptic disorder, congenital nonprogressive
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Diabetes Mellitus, Experimental
|
0.200 |
Biomarker
|
disease |
RGD |
Changes in rhodopsin kinase and transducin in the rat retina in early-stage diabetes.
|
15939031 |
2005 |
Nyctalopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Strabismus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Reduced visual acuity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Severe myopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Blindness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Pallor of optic disc
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypoplasia of optic disc
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Nystagmus, CTCAE 3.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of macular pigmentation
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Nystagmus, CTCAE 5.0
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
Cells transfected with lnc‑GNAT1‑1 were used to initiate gastric cancer tumor xenografts to compare tumor growth in mice inoculated with untransfected cells.
|
30132541 |
2018 |
Retinitis Pigmentosa
|
0.020 |
Biomarker
|
disease |
BEFREE |
<b>Abbreviations</b>: CYCS: cytochrome c; bRHO<sup>P23H</sup>: bovine RHO<sup>P23H</sup>; Cas9: CRISPR associated protein 9; dpf: days post-fertilization; eGFP: enhanced green fluorescent protein; GNAT1: guanine nucleotide-binding protein G(t) subunit alpha-1 aka rod alpha-transducin; HSPA1A/hsp70: heat shock protein of 70 kilodaltons; LAMP1: lysosomal-associated membrane protein 1; LC3: microtubule-associated protein 1A/1B light chain 3; mRFP: monomeric red fluorescent protein; RHO: rhodopsin; RP: retinitis pigmentosa; RPE65: retinal pigment epithelium-specific 65 kDa protein: sfGFP: superfolding GFP; sgRNA: single guide RNA; WGA: wheat germ agglutinin; <i>RHO<sub>p</sub></i>: the <i>Xenopus laevis RHO.2.L</i> promoter.
|
30975014 |
2019 |
Night blindness, stationary
|
0.020 |
Biomarker
|
disease |
BEFREE |
These data suggest that some truncating GNAT1 variants can indeed cause a recessive, mild, late-onset retinal degeneration in human beings rather than just stationary night-blindness as reported previously, with notable similarities to the phenotype of the Gnat1 knockout mouse.
|
26472407 |
2016 |
Colorectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In vitro experiments showed that knockdown of lnc-GNAT1-1 could inhibit the aggressive phenotypes of CRC cell lines.
|
27912775 |
2016 |
Diabetes
|
0.010 |
Biomarker
|
disease |
BEFREE |
In Gnat1-deficient animals, the diabetes-induced increase in expression of inflammatory associated proteins (iNOS and ICAM-1, and phosphorylation of IĸB) in the retina, and the leukocyte mediated killing of retinal endothelial cells were inhibited, however the diabetes-mediated induction of oxidative stress was not inhibited.
|
30994864 |
2019 |
Diabetes Mellitus
|
0.010 |
Biomarker
|
group |
BEFREE |
In Gnat1-deficient animals, the diabetes-induced increase in expression of inflammatory associated proteins (iNOS and ICAM-1, and phosphorylation of IĸB) in the retina, and the leukocyte mediated killing of retinal endothelial cells were inhibited, however the diabetes-mediated induction of oxidative stress was not inhibited.
|
30994864 |
2019 |
Diabetic Retinopathy
|
0.010 |
Biomarker
|
disease |
BEFREE |
We investigated the role of rod cell phototransduction on the pathogenesis of early diabetic retinopathy (DR) using Gnat1-/- mice (which causes permanent inhibition of phototransduction in rod cells without degeneration).
|
30994864 |
2019 |
LATE-ONSET RETINAL DEGENERATION (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
These data suggest that some truncating GNAT1 variants can indeed cause a recessive, mild, late-onset retinal degeneration in human beings rather than just stationary night-blindness as reported previously, with notable similarities to the phenotype of the Gnat1 knockout mouse.
|
26472407 |
2016 |
Neoplasms
|
0.020 |
AlteredExpression
|
group |
BEFREE |
We have demonstrated in this study that a novel lncRNA, lnc-GNAT1-1, is low expressed in colorectal cancer tissues and plasma, and acts as a tumor suppressor through regulating RKIP-NF-κB-Snail circuit.
|
27912775 |
2016 |
Malignant neoplasm of stomach
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Lnc‑GNAT1‑1 overexpression inhibited gastric cancer cell migration and invasion.
|
30132541 |
2018 |
Secondary malignant neoplasm of liver
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Expression of lnc-GNAT1-1 was decreased in liver metastasis than the primary tumor, while the later one is lower than the paired normal mucosa.
|
27912775 |
2016 |
Stomach Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Lnc‑GNAT1‑1 overexpression inhibited gastric cancer cell migration and invasion.
|
30132541 |
2018 |